Ningbo Menovo Pharmaceutical (603538.SS) Earnings Analysis
Ningbo Menovo Pharmaceutical (603538.SS) has no confirmed upcoming earnings date. Trailing P/E 57.85.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 603538.SS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 603538.SS. This page updates as the calendar is published.
603538.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-04-25 | 0.0289 CNY | n/a | n/a | n/a |
| 2025-08-27 | 0.12 CNY | n/a | n/a | n/a |
| 2025-04-30 | 0.1 CNY | n/a | n/a | n/a |
| 2025-04-18 | 0.0171 CNY | n/a | n/a | n/a |
| 2024-10-30 | 0.19 CNY | n/a | n/a | n/a |
| 2024-08-30 | 0.0222 CNY | n/a | n/a | n/a |
603538.SS valuation and analyst view
| Trailing P/E | 57.85 |
|---|---|
| Trailing EPS | 0.50394 CNY |
| Price / book | 2.70 |
| Dividend yield | 0.54% |
| Market cap | 9.94B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Ningbo Menovo Pharmaceutical (603538.SS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 603538.SS. This page updates as the calendar is published.
Did 603538.SS beat earnings last quarter?
Consensus estimate data was not available for 603538.SS's 2026-04-25 report.
What is 603538.SS's current P/E ratio and EPS?
603538.SS trades at a trailing P/E of 57.85 on trailing EPS of 0.5039382883831822 CNY.
What do analysts rate 603538.SS?
603538.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.